InvestingKiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial of Deltacel by TheCompaniesMay 1, 20230 Share0 Facebook Twitter Google+ Pinterest Amazon reddit LinkedIn Myspace
